Key Area Objectives

Mother-to-child transmission, Palliative Care, Treatment, STI treatment

Detailed Description of Key Areas

Mother-to-child transmission

• Primary prevention – including protection of women of reproductive age from HIV
• Family planning services – including safe and volunatry abortions, when necessary
• VCT services – which, where and for who
• Stigma and discrimination relating to MTCT, children born from HIV positive mothers, HIV positive mothers and their rights
• Strengthening Antenatal facilities – including provision for HIV testing
• Training – for staff involved in MTCT
• Purchasing and storage of ARV drugs and replacement feeding
• Counseling – before notification of results, during ARV regimen and for follow-up
• Management and administration – including planning and supervision of project and follow-up of mothers and infants

Palliative Care

• Palliative services – home care, in-hospice care, multi-disciplinary palliative care teams in hospitals, day centers, etc.
• Access to palliative services
• Medication and other materials and equipment needed
• Development, production and distribution of IEC materials on Palliative Care
• Training – of all staff and particularly of the infectionists who will have responsibility for working withPLHA; includes refresher training. Some training sessions of family members of PLHA and NGOs should also be taken into account
• Strengthening Palliative Care facilities – including costs for palliative care units
• Implementation of curriculum – comprises development of curriculum on PC for medical educational settings
• Management and administration – including planning, supervision and evaluation

Treatment

• Training – of all staff and particularly of the infectionists who will have responsibility for working withPLHA; includes refresher training
• Strengthening of hospital facilities – including diagnostic equipment, medical equipment and consumables
• Implementation of curriculum – comprises development of curriculum on ARV for medical educational settings
• Supply and storage of ARV drugs and drugs for opportunistic infections – before notification of results, during ARV regimen and for follow-up
• Management and administration – including planning, supervision and evaluation

STI treatment

• Development/distribution of diagnostic and treatment protocols – including strengthening of existing laboratory facilities
• Training – including clinical and support staff
• Diagnosis – includes both laboratory and syndromic diagnosis
• Counseling – including drug and condom provision
• Partner notification – partner tracing, notification and counseling
• Management and administration – including planning, supervision and evaluation